Trial Profile
Dual anti-platelet therapy with with clopidogrel or prasugrel patients at a risk of very late stent thrombosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Oct 2016
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary) ; Aspirin
- Indications Acute coronary syndromes
- Focus Adverse reactions; Therapeutic Use
- 07 Oct 2016 New trial record